Evidence map›Paper›PMID 35774400›Full record

ArticleFrontiers in cellular and infection microbiology2022

Synergistic Microbicidal Effect of AUR and PEITC Against

Haoran Chen, Ning Yang, Liang Yu, Jiajia Li, Hui Zhang, Yahong Zheng, Mengran Xu, Yanyan Liu, Yi Yang, Jiabin Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Drug Repurposing: An Emerging Strategy inJournal of microbiology and biotechnology · 2025
    Review
  3. Article
  4. Article
  5. Nicorandil reduces the antimicrobial effectiveness of polymyxin E againstFrontiers in cellular and infection microbiology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Design and Synthesis of Novel Antimicrobial Agents.Antibiotics (Basel, Switzerland) · 2023
    Review
  12. Mechanism of Synergy between Piceatannol and Ciprofloxacin againstInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Haoran ChenDepartment of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Ning YangDepartment of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Liang YuDepartment of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jiajia LiThe Center for Scientific Research, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Hui ZhangDepartment of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yahong ZhengDepartment of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Mengran XuDepartment of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yanyan LiuDepartment of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yi YangDepartment of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jiabin LiDepartment of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the increasing prevalence of

Indexed as

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnimalsAnti-Bacterial AgentsAuranofinIsothiocyanatesMiceMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsAuranofinIsothiocyanatesphenethyl isothiocyanateauranofin (AUR)phenethyl isothiocyanate (PEITC)reactive oxygen species (ROS)skin infectionsStaphylococcus aureusthioredoxin reductase (TrxR)

Identifiers

PMID35774400
PMCPMC9237442
OpenAlexW4282834621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.